Uncategorised - European Medical Journal

Large Genomic Study Identifies Genetic Markers for Male Baldness

THE RESULTS of a large genomic study using data from over 52,000 males has identified over 250 independent genetic loci associated with pattern baldness.

Virtual Reality Project Awarded £20 Million in Funding for Cancer Research

CANCER RESEARCH UK has awarded millions in funding to scientists at the University of Cambridge, Cambridge, UK, who will build three-dimensional (3D)…

Ophthalmology Cystinosis Forum Morning Session

This 1-day meeting was held at the Austria Trend Savoyen Hotel, Vienna, Austria. The morning session consisted of a series of presentations by experts in…

Ophthalmology Cystinosis Forum Afternoon Session

This 1-day meeting was held at the Austria Trend Savoyen Hotel, Vienna, Austria. The afternoon, chaired by Dr Hong Liang and Dr Rachel Bishop…

Nanoparticles Reactivate Dormant Viruses Within the Lungs

NANOPARTICLES produced by combustion engines may activate viruses that lie dormant in cells of the lung tissue, according to the results of a recently…

Potential Association Found Between Asthma and Childhood Obesity

A POSSIBLE association between obesity and asthma has been found according to the results of a new study; more specifically in early-life asthma which…

Insuficiencia venosa crónica: manejo y tratamiento

La EVC es una enfermedad preocupante que genera una carga significativa sobre los servicios sanitarios y la sociedad en general.

Chronic Venous Insufficiency: Management and Treatment

CVD is a very concerning condition which creates a significant burden on healthcare provision and wider society. Varicose veins are often the first sign of CVD.

A New Treatment Option for Malaria?

THE DISCOVERY of a protein that assists parasites in attacking human red blood cells could be used to develop more developed vaccines for the disease…

BIAL and Neurocrine Announce Exclusive North American Licensing Agreement for Opicapone

Porto, Portugal and San Diego, California, February 10, 2017 – BIAL and Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that they have…